Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Removal of epoxiconazole and pyraclostrobin from highly contaminated effluent (grams per liter level): Comparison between ozone and solar still decontamination using real field conditions.

Hoff R, Furtado R, Dos Santos JM, Vogelmann ES, Hoff GD, Kneip RC, Jank L, Gonçalves FF.

Sci Total Environ. 2018 Nov 5;653:597-604. doi: 10.1016/j.scitotenv.2018.11.043. [Epub ahead of print]

PMID:
30414588
2.

Evaluating gut microbiota profiles from archived fecal samples.

Rounge TB, Meisal R, Nordby JI, Ambur OH, de Lange T, Hoff G.

BMC Gastroenterol. 2018 Nov 8;18(1):171. doi: 10.1186/s12876-018-0896-6.

3.

Long-Term Effectiveness of Sigmoidoscopy Screening in Women and Men.

Holme Ø, Løberg M, Kalager M, Bretthauer M, Hoff G.

Ann Intern Med. 2018 Nov 6;169(9):663-664. doi: 10.7326/L18-0512. No abstract available.

PMID:
30398636
4.

Improving Cancer Preventive Behaviors: A Randomized Trial of Tailored Lifestyle Feedback in Colorectal Cancer Screening.

Knudsen MD, Hjartåker A, Robb KA, de Lange T, Hoff G, Berstad P.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1442-1449. doi: 10.1158/1055-9965.EPI-18-0268. Epub 2018 Nov 2.

PMID:
30389802
5.

Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.

Jodal HC, Løberg M, Holme Ø, Adami HO, Bretthauer M, Emilsson L, Ransohoff DF, Hoff G, Kalager M.

Gastroenterology. 2018 Dec;155(6):1787-1794.e3. doi: 10.1053/j.gastro.2018.08.035. Epub 2018 Aug 27.

PMID:
30165051
6.

Bond-Breaking Efficiency of High-Energy Ions in Ultrathin Polymer Films.

Thomaz R, Louette P, Hoff G, Müller S, Pireaux JJ, Trautmann C, Papaléo RM.

Phys Rev Lett. 2018 Aug 10;121(6):066101. doi: 10.1103/PhysRevLett.121.066101.

PMID:
30141670
7.

Polypectomy techniques among gastroenterologists in Norway - a nationwide survey.

Pedersen IB, Løberg M, Hoff G, Kalager M, Bretthauer M, Holme Ø.

Endosc Int Open. 2018 Jul;6(7):E812-E820. doi: 10.1055/a-0607-0727. Epub 2018 Jul 4.

8.

Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.

Pinsky PF, Loberg M, Senore C, Wooldrage K, Atkin W, Bretthauer M, Cross AJ, Hoff G, Holme O, Kalager M, Segnan N, Schoen RE.

Gastroenterology. 2018 Oct;155(4):1059-1068.e2. doi: 10.1053/j.gastro.2018.06.040. Epub 2018 Jun 20.

PMID:
29935150
9.

Tailoring the message with selective reporting.

Løberg M, Kalager M, Hoff G.

Eur J Epidemiol. 2018 Aug;33(8):773. doi: 10.1007/s10654-018-0416-6. Epub 2018 May 30. No abstract available.

PMID:
29846866
10.

Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.

Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Lekven J, Schneede J, Tveit KM, Vatn M, Ursin G, Hoff G; NORCCAP Study Group†.

Ann Intern Med. 2018 Jun 5;168(11):775-782. doi: 10.7326/M17-1441. Epub 2018 Apr 24.

PMID:
29710125
11.

Genome plasticity is governed by double strand break DNA repair in Streptomyces.

Hoff G, Bertrand C, Piotrowski E, Thibessard A, Leblond P.

Sci Rep. 2018 Mar 27;8(1):5272. doi: 10.1038/s41598-018-23622-w.

12.

Endoscopy assistants influence the quality of colonoscopy.

Holme Ø, Pedersen IB, Medhus AW, Aabakken L, Glomsaker T, Kvamme JM, Løberg M, Bretthauer M, Seip B, Kjellevold Ø, Jørgensen A, Furholm S, Hoff G, de Lange T.

Endoscopy. 2018 Sep;50(9):871-877. doi: 10.1055/s-0044-101706. Epub 2018 Feb 14.

PMID:
29444529
13.

Optimalisering gjennom randomisering.

Hoff G, Lange T, Ursin G.

Tidsskr Nor Laegeforen. 2017 Oct 30;137(20). doi: 10.4045/tidsskr.17.0876. Print 2017 Oct 31. Norwegian. No abstract available.

PMID:
29094557
Free Article
14.

Modifiable factors associated with patient-reported pain during and after screening colonoscopy.

Bugajski M, Wieszczy P, Hoff G, Rupinski M, Regula J, Kaminski MF.

Gut. 2018 Nov;67(11):1958-1964. doi: 10.1136/gutjnl-2017-313905. Epub 2017 Sep 28.

PMID:
28970289
15.

Acceptability of two colorectal cancer screening tests: pain as a key determinant in sigmoidoscopy.

Kirkøen B, Berstad P, Botteri E, Dalén E, Nilsen JA, Hoff G, de Lange T, Bernklev T.

Endoscopy. 2017 Nov;49(11):1075-1086. doi: 10.1055/s-0043-117400. Epub 2017 Sep 22.

PMID:
28938500
16.

Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.

Knudsen MD, Berstad P, Hjartåker A, Gulichsen EH, Hoff G, de Lange T, Bernklev T, Botteri E.

Br J Cancer. 2017 Aug 8;117(4):461-469. doi: 10.1038/bjc.2017.189. Epub 2017 Jul 13.

17.

Cecum intubation rate as quality indicator in clinical versus screening colonoscopy.

Hoff G, Holme Ø, Bretthauer M, Sandvei P, Darre-Næss O, Stallemo A, Wiig H, Høie O, Noraberg G, Moritz V, de Lange T.

Endosc Int Open. 2017 Jun;5(6):E489-E495. doi: 10.1055/s-0043-106180. Epub 2017 May 31.

18.

Sigmoidoscopy and faecal occult blood test - a comparative screening trial.

Lange T, Randel KR, Schult AL, Knudsen MD, Kirkøen B, Botteri E, Berstad P, Jørgensen A, Ursin G, Bretthauer M, Hoff G.

Tidsskr Nor Laegeforen. 2017 May 23;137(10):727-730. doi: 10.4045/tidsskr.16.1031. eCollection 2017 May. English, Norwegian. No abstract available.

19.

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative.

Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S, Ferlitsch M, Anderson J, Roesch T, Hultcranz R, Racz I, Kuipers EJ, Garborg K, East JE, Rupinski M, Seip B, Bennett C, Senore C, Minozzi S, Bisschops R, Domagk D, Valori R, Spada C, Hassan C, Dinis-Ribeiro M, Rutter MD.

United European Gastroenterol J. 2017 Apr;5(3):309-334. doi: 10.1177/2050640617700014. Epub 2017 Mar 16. Review.

20.

Patient-reported adverse events after colonoscopy in Norway.

Hoff G, de Lange T, Bretthauer M, Buset M, Dahler S, Halvorsen FA, Halwe JM, Heibert M, Høie O, Kjellevold Ø, Moritz V, Sandvei P, Seip B, Aabakken L, Holme Ø.

Endoscopy. 2017 Aug;49(8):745-753. doi: 10.1055/s-0043-105265. Epub 2017 Apr 26.

PMID:
28445903
21.

Monte Carlo Simulation Used to Calculate Energy Correction Factor for Thermoluminescent Dosimeters Used by Occupational Workers on Pediatric Exams.

Hoff G, Filipov D, Paschuk S, Schelin HR, Denyak V.

Radiat Prot Dosimetry. 2017 Dec 1;177(3):223-242. doi: 10.1093/rpd/ncx036.

PMID:
28419323
22.

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative.

Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S, Ferlitsch M, Anderson J, Roesch T, Hultcranz R, Racz I, Kuipers EJ, Garborg K, East JE, Rupinski M, Seip B, Bennett C, Senore C, Minozzi S, Bisschops R, Domagk D, Valori R, Spada C, Hassan C, Dinis-Ribeiro M, Rutter MD.

Endoscopy. 2017 Apr;49(4):378-397. doi: 10.1055/s-0043-103411. Epub 2017 Mar 7.

23.

Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials.

Holme Ø, Schoen RE, Senore C, Segnan N, Hoff G, Løberg M, Bretthauer M, Adami HO, Kalager M.

BMJ. 2017 Jan 13;356:i6673. doi: 10.1136/bmj.i6673.

24.

Multiple and Variable NHEJ-Like Genes Are Involved in Resistance to DNA Damage in Streptomyces ambofaciens.

Hoff G, Bertrand C, Zhang L, Piotrowski E, Chipot L, Bontemps C, Confalonieri F, McGovern S, Lecointe F, Thibessard A, Leblond P.

Front Microbiol. 2016 Nov 28;7:1901. eCollection 2016.

25.

Psychological effects of colorectal cancer screening: Participants vs individuals not invited.

Kirkøen B, Berstad P, Botteri E, Bernklev L, El-Safadi B, Hoff G, de Lange T, Bernklev T.

World J Gastroenterol. 2016 Nov 21;22(43):9631-9641.

26.

Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study.

Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP, Opheim R, Henriksen M, Høie O, Hovde Ø, Kempski-Monstad I, Solberg IC, Jahnsen J, Hoff G, Moum B, Bernklev T.

Scand J Gastroenterol. 2017 Mar;52(3):351-358. doi: 10.1080/00365521.2016.1256425. Epub 2016 Nov 17. Erratum in: Scand J Gastroenterol. 2017 May;52(5):i.

PMID:
27852169
27.

Changes in health behavior 1 year after testing negative at a colorectal cancer screening: a randomized-controlled study.

Knudsen MD, Hjartåker A, Olsen MKE, Hoff G, de Lange T, Bernklev T, Berstad P.

Eur J Cancer Prev. 2018 Jul;27(4):316-322. doi: 10.1097/CEJ.0000000000000328.

PMID:
27824661
28.

America, We Are Confused: The Updated U.S. Preventive Services Task Force Recommendation on Colorectal Cancer Screening.

Bretthauer M, Kaminski MF, Hassan C, Kalager M, Holme Ø, Hoff G, Løberg M, Regula J, Castells A, Adami HO.

Ann Intern Med. 2017 Jan 17;166(2):139-140. doi: 10.7326/M16-1805. Epub 2016 Nov 8. No abstract available.

PMID:
27820949
29.

Colorectal Cancer Screening.

Holme Ø, Hoff G, Løberg M.

JAMA. 2016 Oct 25;316(16):1714. doi: 10.1001/jama.2016.13846. No abstract available.

PMID:
27784085
30.

Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.

Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M, Venstrom JM, Verneris MR.

Biol Blood Marrow Transplant. 2017 Jan;23(1):153-160. doi: 10.1016/j.bbmt.2016.09.028. Epub 2016 Oct 13.

31.

Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.

Lorentzen JA, Grzyb K, De Angelis PM, Hoff G, Eide TJ, Andresen PA.

Clin Med Insights Pathol. 2016 Sep 7;9:19-28. doi: 10.4137/CPath.s40143. eCollection 2016.

32.

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis.

Huppertz-Hauss G, Aas E, Lie Høivik M, Langholz E, Odes S, Småstuen M, Stockbrugger R, Hoff G, Moum B, Bernklev T.

Gastroenterol Res Pract. 2016;2016:5023973. doi: 10.1155/2016/5023973. Epub 2016 Aug 18.

33.

Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia.

Knudsen MD, de Lange T, Botteri E, Nguyen DH, Evensen H, Steen CB, Hoff G, Bernklev T, Hjartåker A, Berstad P.

World J Gastroenterol. 2016 Jul 21;22(27):6276-86. doi: 10.3748/wjg.v22.i27.6276.

34.

Implication of RuvABC and RecG in homologous recombination in Streptomyces ambofaciens.

Hoff G, Bertrand C, Piotrowski E, Thibessard A, Leblond P.

Res Microbiol. 2017 Jan;168(1):26-35. doi: 10.1016/j.resmic.2016.07.003. Epub 2016 Jul 15.

35.

Lifestyle changes at middle age and mortality: a population-based prospective cohort study.

Berstad P, Botteri E, Larsen IK, Løberg M, Kalager M, Holme Ø, Bretthauer M, Hoff G.

J Epidemiol Community Health. 2017 Jan;71(1):59-66. doi: 10.1136/jech-2015-206760. Epub 2016 Jun 16.

PMID:
27312250
36.

Routine vs. on-demand analgesia in colonoscopy: a randomized clinical trial.

Holme Ø, de Lange T, Stallemo A, Wiig H, Hasund A, Dvergsnes K, Garborg K, Ystrøm CM, Løberg M, Hoff G, Bretthauer M, Kalager M.

Endoscopy. 2016 Sep;48(9):823-8. doi: 10.1055/s-0042-108433. Epub 2016 Jun 15.

PMID:
27305424
37.

Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial.

Bretthauer M, Kaminski MF, Løberg M, Zauber AG, Regula J, Kuipers EJ, Hernán MA, McFadden E, Sunde A, Kalager M, Dekker E, Lansdorp-Vogelaar I, Garborg K, Rupinski M, Spaander MC, Bugajski M, Høie O, Stefansson T, Hoff G, Adami HO; Nordic-European Initiative on Colorectal Cancer (NordICC) Study Group.

JAMA Intern Med. 2016 Jul 1;176(7):894-902. doi: 10.1001/jamainternmed.2016.0960.

38.

Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study.

Huppertz-Hauss G, Lie Høivik M, Jelsness-Jørgensen LP, Henriksen M, Høie O, Jahnsen J, Hoff G, Moum B, Bernklev T.

Inflamm Bowel Dis. 2016 Jul;22(7):1679-87. doi: 10.1097/MIB.0000000000000806.

PMID:
27206016
39.

Who Is for CO2? Slow Adoption of Carbon Dioxide Insufflation in Colonoscopy.

Bretthauer M, Kalager M, Adami HO, Hoff G.

Ann Intern Med. 2016 Jul 19;165(2):145-6. doi: 10.7326/M16-0209. Epub 2016 May 10. No abstract available.

PMID:
27159139
40.

Identification of multiple nursery habitats of skates in the eastern Bering Sea.

Hoff GR.

J Fish Biol. 2016 May;88(5):1746-57. doi: 10.1111/jfb.12939. Epub 2016 Apr 7.

PMID:
27062636
41.

Rationale and design of the European Polyp Surveillance (EPoS) trials.

Jover R, Bretthauer M, Dekker E, Holme Ø, Kaminski MF, Løberg M, Zauber AG, Hernán MA, Lansdorp-Vogelaar I, Sunde A, McFadden E, Castells A, Regula J, Quintero E, Pellisé M, Senore C, Kalager M, Dinis-Ribeiro M, Emilsson L, Ransohoff DF, Hoff G, Adami HO.

Endoscopy. 2016 Jun;48(6):571-8. doi: 10.1055/s-0042-104116. Epub 2016 Apr 4.

42.

An explorative study from the Norwegian Quality Register Gastronet comparing self-estimated versus registered quality in colonoscopy performance.

Moritz V, Holme O, Leblanc M, Hoff G.

Endosc Int Open. 2016 Mar;4(3):E326-32. doi: 10.1055/s-0042-100904. Epub 2016 Feb 10.

43.

Time trends in quality indicators of colonoscopy.

Moritz V, Bretthauer M, Holme Ø, Wang Fagerland M, Løberg M, Glomsaker T, de Lange T, Seip B, Sandvei P, Hoff G.

United European Gastroenterol J. 2016 Feb;4(1):110-20. doi: 10.1177/2050640615570147. Epub 2015 Feb 5.

44.

Do no harm: no psychological harm from colorectal cancer screening.

Kirkøen B, Berstad P, Botteri E, Åvitsland TL, Ossum AM, de Lange T, Hoff G, Bernklev T.

Br J Cancer. 2016 Mar 1;114(5):497-504. doi: 10.1038/bjc.2016.14. Epub 2016 Feb 11.

45.

Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer.

Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ.

Cancer. 2016 Mar 15;122(6):826-39. doi: 10.1002/cncr.29865. Epub 2016 Feb 1.

46.

Look to Poland! Conversion from opportunistic screening to a randomized, national screening program for colorectal cancer.

Hoff G.

Endoscopy. 2015 Dec;47(12):1104-5. doi: 10.1055/s-0034-1393430. Epub 2015 Dec 2. No abstract available.

PMID:
26630335
47.

Bounding the per-protocol effect in randomized trials: an application to colorectal cancer screening.

Swanson SA, Holme Ø, Løberg M, Kalager M, Bretthauer M, Hoff G, Aas E, Hernán MA.

Trials. 2015 Nov 30;16:541. doi: 10.1186/s13063-015-1056-8.

48.

Methods to Estimate the Comparative Effectiveness of Clinical Strategies that Administer the Same Intervention at Different Times.

Huitfeldt A, Kalager M, Robins JM, Hoff G, Hernán MA.

Curr Epidemiol Rep. 2015 Sep 1;2(3):149-161. Epub 2015 Jul 24.

49.

Gastrointestinal cancer screening: screening may release new research funding to improve health service also in routine clinics.

Hoff G.

Scand J Gastroenterol. 2015 Jun;50(6):718-26. doi: 10.3109/00365521.2015.1011225. Epub 2015 Apr 10. Review.

PMID:
25857737
50.

Neighborhood socio-economic context and emergency department visits for dental care in a U.S. Midwestern metropolis.

Hong L, Liu Y, Hottel TL, Hoff GL, Cai J.

Public Health. 2015 Mar;129(3):252-7. doi: 10.1016/j.puhe.2014.11.014. Epub 2015 Feb 19.

PMID:
25702034

Supplemental Content

Support Center